Abstract
Objectives: The BIV1-CovIran vaccine is highly effective against COVID-19. The neutralizing potency of all SARS-CoV-2 vaccines seems to be decreased against variants of concern. We assessed the sensitivity of the Alpha (B.1.1.7), Beta (B.1.351), and Delta (B.1.617.2) variants to neutralizing antibodies (NAbs) present in sera from individuals who had received the BIV1-CovIran candidate vaccine compared with an original Wuhan-related strain.
Methods: The ability of vaccine serum to neutralize the variants was measured using the conventional virus neutralization test. The correlation of spike (S) protein antibody and anti-receptor binding domain with neutralizing activity was investigated.
Results: The current study demonstrated that 29 of 32 (90.6%; 95% CI: 75.0-98.0) of the vaccinees developed NAbs against a Wuhan-related strain. It is noteworthy that 28 (87.50%) and 24 of 32 (75%) of the recipients were able to produce NAbs against Alpha, Beta, and Delta variants, respectively. Serum virus-neutralizing titres for different SARS-CoV-2 strains were weakly correlated with anti-receptor binding domain antibodies (Spearman r = 36-42, p < 0.05), but not S-binding antibodies (p > 0.05).
Discussion: Although there was a reduction in neutralization titres against the Alpha, Beta, and Delta variants compared with the Wuhan strain, BIV1-CovIran still exhibited potent neutralizing activity against the SARS-CoV-2 variants of concern.
Keywords: BIV1-CovIran vaccine; COVID-19 vaccine; SARS-CoV-2 variants; Virus neutralization test.
【저자키워드】 COVID-19 vaccine, SARS-CoV-2 variants, virus neutralization test, BIV1-CovIran vaccine, 【초록키워드】 COVID-19, neutralizing antibody, SARS-CoV-2, Vaccine, COVID-19 vaccine, Neutralizing antibodies, antibody, B.1.351, neutralization, variant, variants of concern, Delta, B.1.617.2, delta variant, variants, SARS-CoV-2 vaccine, Protein, serum, sensitivity, Neutralizing activity, SARS-CoV-2 variants, B.1.1.7, sera, virus neutralization test, neutralization test, Alpha, Beta, Neutralizing, correlation, NAb, Delta variants, recipients, individual, NAbs, candidate vaccine, titre, Wuhan strain, binding domain, vaccinees, recipient, SARS-CoV-2 strain, conventional virus neutralization test, Spearman, effective, neutralize, vaccinee, was measured, investigated, exhibited, demonstrated, correlated, virus-neutralizing, reduction in, the SARS-CoV-2, 【제목키워드】 neutralizing antibody, SARS-CoV-2 variant, assessment, inactivated,